AMYLIN PHARMACEUTICALS INC·4

Feb 4, 7:20 PM ET

MARCHETTI ROGER 4

4 · AMYLIN PHARMACEUTICALS INC · Filed Feb 4, 2010

Insider Transaction Report

Form 4
Period: 2010-02-02
MARCHETTI ROGER
Sr VP HR & Information Mgmt
Transactions
  • Award

    Common Stock

    2010-02-03$17.83/sh+412$7,3466,473 total
  • Award

    Common Stock

    2010-02-03+1,3604,815 total(indirect: by ESOP)
  • Award

    Incentive Stock Option (right to buy)

    2010-02-02+6,3316,331 total
    Exercise: $18.01Exp: 2017-02-02Common Stock (6,331 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2010-02-02+53,66953,669 total
    Exercise: $18.01Exp: 2017-02-02Common Stock (53,669 underlying)
Footnotes (4)
  • [F1]Represents shares acquired pursuant to the Company's 401(k) plan.
  • [F2]Direct holdings include 2 shares acquired on August 31, 2009 under the company's employee stock purchase plan and fractional share amounts deposited to participant's 401(k) account by the trustee to cover interest accrued on cash balances in the plan's stock fund.
  • [F3]These shares fully vest four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
  • [F4]25% of shares vest one year from date of grant and the remainder vest monthly over the next three years becoming fully vested four years from date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT